France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to France In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in France

Scope

- The report provides information on the French in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in France.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
 

Ventana Medical Systems, Inc.
Sysmex Corporation
Siemens Healthcare
Qiagen N.V.
Phadia AB
Ortho-Clinical Diagnostics Inc.
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Hologic, Inc.
Gen-Probe Incorporated
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A
Dade Behring Holdings, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Beckman Coulter, Inc.
Abbott Laboratories
Argene S.A.
Biocode Hycel
GEMAC S.A.
ExonHit Therapeutics SA
EUROMEDEX
Diagnostica Stago
The Elitech Group
 

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Healthcare Sector Review
4.1 Healthcare Sector Review
4.2 Healthcare Expenditure
4.3 Healthcare Infrastructure
4.4 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement Policies
7 Distribution Structure
7.1 France Medical Equipment Distribution Structure
8 In Vitro Diagnostics In France
8.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, France, Company Share (2007-2008)
9 Clinical Chemistry In France
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, France, Company Share (2007-2008)
10 Genetic Testing In France
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, France, Company Share (2007-2008)
11 Haematology In France
11.1 Haematology Overall Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, France, Company Share (2007-2008)
12 Histology and Cytology In France
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.2 Histology And Cytology Distribution Share (2007-2008)
12.3 Histology And Cytology, France, Company Share (2007-2008)
13 Immuno Chemistry In France
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, France, Company Share (2007-2008)
14 Infectious Immunology In France
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, France, Company Share (2007-2008)
15 Microbiology Culture In France
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, France, Company Share (2007-2008)
16 Overview of Key Companies in France In Vitro Diagnostics Market
16.1 Ventana Medical Systems, Inc.
16.2 Sysmex Corporation
16.3 Siemens Healthcare
16.4 Qiagen N.V.
16.5 Phadia AB
16.6 Ortho-Clinical Diagnostics Inc.
16.7 OLYMPUS CORPORATION
16.8 Inverness Medical Innovations, Inc.
16.9 Hologic, Inc.
16.10 Gen-Probe Incorporated
16.11 F. Hoffmann-La Roche Ltd.
16.12 DiaSorin S.p.A
16.13 Dade Behring Holdings, Inc.
16.14 Bio-Rad Laboratories, Inc.
16.15 bioMerieux S.A.
16.16 Becton, Dickinson and Company
16.17 Beckman Coulter, Inc.
16.18 Abbott Laboratories
16.19 Argene S.A.
16.20 Biocode Hycel
16.21 GEMAC S.A.
16.22 ExonHit Therapeutics SA
16.23 EUROMEDEX
16.24 Diagnostica Stago
16.25 The Elitech Group
17 Financial Deals Landscape
17.1 Partnerships
18 Recent Developments
18.1 Product News
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panel Validation
19.7 Currency Conversion
19.8 Contact Us
19.9 Disclaimer
 

1.1 List of Tables
Table 1: Total Healthcare Expenditure, France, 2000 – 2007 26
Table 2: Number of Doctors by Specialty in France, 2003-2007 29
Table 3: Number of Hospital Wards by Specialty in France, 2003-2007 30
Table 4: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015 48
Table 5: In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015 49
Table 6: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008 51
Table 7: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015 53
Table 8: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2007-2008 54
Table 9: Clinical Chemistry, France, Revenue ($ mn) by Segment, Historic, 2000-2008 56
Table 10: Clinical Chemistry, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 58
Table 11: Clinical Chemistry Analyzers, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 59
Table 12: Clinical Chemistry Analyzers, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 60
Table 13: Urine Analysis, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61
Table 14: Urine Analysis, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 62
Table 15: Clinical Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008 63
Table 16: Clinical Chemistry, France, Company Share by Revenue ($ mn), 2007-2008 64
Table 17: Genetic Testing, France, Revenue ($ mn) by Segment, Historic, 2000-2008 65
Table 18: Genetic Testing, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 66
Table 19: Genetic Testing, France, Distribution Share by Revenue ($mn), 2007-2008 67
Table 20: Genetic Testing, France, Company Share by Revenue ($ mn), 2007-2008 68
Table 21: Haematology, France, Revenue ($ mn) by Segment, Historic, 2000-2008 70
Table 22: Haematology, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 72
Table 23: Haematology Reagents, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Table 24: Haematology Reagents, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Table 25: Immunohaematology, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Table 26: Immunohaematology, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 76
Table 27: Haemostasis, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 78
Table 28: Haemostasis, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 29: Haematology Rapid Tests, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Table 30: Haematology Rapid Tests, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 31: Haematology Cell Counters, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 83
Table 32: Haematology Cell Counters, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 84
Table 33: Haematology, France, Distribution Share by Revenue ($mn), 2007-2008 85
Table 34: Haematology, France, Company Share by Revenue ($ mn), 2007-2008 86
Table 35: Histology And Cytology, France, Revenue ($ mn) by Segment, Historic, 2000-2008 87
Table 36: Histology And Cytology, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 88
Table 37: Histology, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 38: Histology, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Table 39: Histology And Cytology, France, Distribution Share by Revenue ($mn), 2007-2008 91
Table 40: Histology And Cytology, France, Company Share by Revenue ($ mn), 2007-2008 92
Table 41: Immuno Chemistry, France, Revenue ($ mn) by Segment, Historic, 2000-2008 94
Table 42: Immuno Chemistry, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 96
Table 43: Disease Specific Immunochemistry, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 98
Table 44: Disease Specific Immunochemistry, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 100
Table 45: Drug Related Testing, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 101
Table 46: Drug Related Testing, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 102
Table 47: Endocrinology Tests, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 103
Table 48: Endocrinology Tests, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 104
Table